Re:DeepMind readies first commercial product
by dontreact on Tuesday April 02, 2019 @10:32PM
(#19560320)
I think it’s the lack of will to study these sort of things that is dangerous. There just doesn’t seem to be this sense of caution among the people working on this. They seem to just want to jump over the low bar set by the fda and move ahead to patient care.
[ Parent
| on HN ]
There are no comments on this comment yet.